High Mortality in Adults Hospitalized for Active Tuberculosis in a Low HIV Prevalence Setting
Open Access
- 18 March 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (3) , e92077
Abstract
This study aims to evaluate the outcomes of adults hospitalized for tuberculosis in a higher-income region with low HIV prevalence. A retrospective cohort study was conducted on all adults hospitalized for pulmonary and/or extrapulmonary tuberculosis in an acute-care hospital in Hong Kong during a two-year period. Microscopy and solid-medium culture were routinely performed. The diagnosis of tuberculosis was made by: (1) positive culture of M. tuberculosis, (2) positive M. tuberculosis PCR result, (3) histology findings of tuberculosis infection, and/or (4) typical clinico-radiological manifestations of tuberculosis which resolved after anti-TB treatment, in the absence of alternative diagnoses. Time to treatment (‘early’, started during initial admission; ‘late’, subsequent periods), reasons for delay, and short- and long-term survival were analyzed. Altogether 349 patients were studied [median(IQR) age 62(48–77) years; non-HIV immunocompromised conditions 36.7%; HIV/AIDS 2.0%]. 57.9%, 16.3%, and 25.8% had pulmonary, extrapulmonary, and pulmonary-extrapulmonary tuberculosis respectively. 58.2% was smear-negative; 0.6% multidrug-resistant. 43.4% developed hypoxemia. Crude 90-day and 1-year all-cause mortality was 13.8% and 24.1% respectively. 57.6% and 35.8% received ‘early’ and ‘late’ treatment respectively, latter mostly culture-guided [median(IQR) intervals, 5(3–9) vs. 43(25–61) days]. Diagnosis was unknown before death in 6.6%. Smear-negativity, malignancy, chronic lung diseases, and prior exposure to fluoroquinolones (adjusted-OR 10.6, 95%CI 1.3–85.2) delayed diagnosis of tuberculosis. Failure to receive ‘early’ treatment independently predicted higher mortality (Cox-model, adjusted-HR 1.8, 95%CI 1.1–3.0). Mortality of hospitalized tuberculosis patients is high. Newer approaches incorporating methods for rapid diagnosis and initiation of anti-tuberculous treatment are urgently required to improve outcomes.Keywords
This publication has 34 references indexed in Scilit:
- Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care testThe Lancet Infectious Diseases, 2013
- Outcomes of TB Treatment by HIV Status in National Recording Systems in Brazil, 2003–2008PLOS ONE, 2012
- Initial Presentations Predict Mortality in Pulmonary Tuberculosis Patients - A Prospective Observational StudyPLOS ONE, 2011
- TuberculosisThe Lancet, 2011
- Interferon gamma release assay for differentiating tuberculosis among pneumonia cases in acute healthcare settingJournal of Infection, 2011
- In-hospital outcome of patients with culture-confirmed tuberculous pleurisy: clinical impact of pulmonary involvementBMC Infectious Diseases, 2011
- Why is In-hospital Diagnosis of Pulmonary Tuberculosis Delayed in Southern Taiwan?Journal of the Formosan Medical Association, 2010
- Tuberculosis Transmission by Patients with Smear‐Negative Pulmonary Tuberculosis in a Large Cohort in The NetherlandsClinical Infectious Diseases, 2008
- A systematic review of delay in the diagnosis and treatment of tuberculosisBMC Public Health, 2008
- Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosisThorax, 2006